Vaccines broader value advisory board
On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.
During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making.
Inge van der Putten
Also read
-
Three researchers from Maastricht University (UM) will receive a prestigious ERC Starting Grant from the European Research Council. They will receive €1.5 million each. Their funding is part of the EU Horizon Europe programme.
-
In the upcoming months, we’ll share tips on Instagram for our students on how to live a healthier life. Not just a random collection, but tips based on actual research happening at our faculty. The brains behind this idea are Lieve Vonken and Gido Metz, PhD candidates at CAPHRI, the Care and Public...
-
When two passionate minds meet, great things can happen. A few months ago during a Maastricht Social Run, Human Movement Sciences student Lucas ran across Juan, an alumnus of Governance and Leadership in European Public Health. A conversation about training for the IRONMAN® European Championship and...
